The VincoAI, an AI without filter module, is the first Proof-of-Concept (POC) AI, precisely predicts peptide-protein amino acid sequences based on high-quality data. Unlike the Sequential Model Ensemble Pipeline (SMEP), this moonshot project VincoAI develops revolutionary LSTM and Transformer models, to identify peptide-protein candidates in silico. The utility of VincoAI extends beyond antimicrobial resistance (AMR). It can also be utilized in various areas of Biologics research including pathogen and host protein-protein interaction, stem cells, human phageome analysis, peptide drugs, nanobody and T-cell vaccine R&D. VincoAI has the potential to save the time, money, and resources needed for the discovery of PreClinical Candidates (PCC).
Company Details
- Employees
- 3
- Founded
- -
- Address
- Concerns That Patients May Lose Too Much Lean Mass While Shedding Pounds
- Industry
- Biotechnology
- Website
- vincogen.com
Vincogen Corporation Questions
Vincogen Corporation's website is vincogen.com
Vincogen Corporation's LinkedIn profile is https://www.linkedin.com/company/vincogen
Vincogen Corporation has
3 employees.
View email and phone details for 3
employees at Vincogen Corporation.
Vincogen Corporation's industry is
Biotechnology
Vincogen Corporation's top competitors are
Imx Medical Management Services,
Genobank.io,
Ia University Powered By Mdalatam,
Runner's Roost,
Me Therapeutics,
Kyverna Therapeutics,
Horizon Innovations Market,
Reel.dev,
Windmil Therapeutics,
Owl Therapeutics.
Vincogen Corporation's categories are Biotechnology
Vincogen Corporation's founding year is 2000
